Lena Birgitta Degling Wikingsson
Directeur/Membre du Conseil chez ALZINOVA AB
Provenance du réseau au premier degré de Lena Birgitta Degling Wikingsson
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
17
| Public Company | Pharmaceuticals: Major | 17 |
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden.
12
| Holding Company | Pharmaceuticals: Major | 12 |
10
| Public Company | Biotechnology | 10 |
XNK Therapeutics AB
 XNK Therapeutics AB Pharmaceuticals: MajorHealth Technology XNK Therapeutics AB operates as a technology platform which leads research on NK cells at Karolinska Institutet in Stockholm. The company was founded in 2012 and is headquartered in Huddinge, Sweden.
8
| Private Company | Pharmaceuticals: Major | 8 |
CellProtect Nordic Pharmaceuticals AB
 CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Part of XNK Therapeutics AB, CellProtect Nordic Pharmaceuticals AB is a clinical-stage biotechnology company based in Huddinge, SE. CellProtect Nordic Pharmaceuticals is one of the pioneering companies in the field of cell therapy, developing unique and individualized natural killer (NK) cell-based cancer therapies. The Swedish company has built a tailor-made GMP clean room facility for manufacturing clinical products and is currently evaluating its lead product, evencaleucel, in a randomized, controlled, phase II study for the treatment of multiple myeloma. The private company was founded in 2012 and the CEO is Johan Liwing.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
| Public Company | Pharmaceuticals: Major | 3 | |
Dilafor Incentive AB
1
| Private Company | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Lena Birgitta Degling Wikingsson via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of Uppsala | College/University | Graduate Degree Masters Business Admin Doctorate Degree Graduate Degree Graduate Degree Masters Business Admin Graduate Degree Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Doctorate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Masters Business Admin Masters Business Admin | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| MENDUS AB | Biotechnology | Chairman Director/Board Member General Counsel | |
| FORWARD PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
| TOLERANZIA AB | Biotechnology | Director/Board Member Director of Finance/CFO | |
| LIPIGON PHARMACEUTICALS AB | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| VIVESTO AB | Pharmaceuticals: Generic | Chief Executive Officer Director of Finance/CFO | |
| University of Gothenburg | College/University | Doctorate Degree Graduate Degree | |
| ELICERA THERAPEUTICS AB | Biotechnology | Chairman Director/Board Member | |
| INDEX PHARMACEUTICALS HOLDING AB | Pharmaceuticals: Major | Chairman Chief Operating Officer | |
| Hunterhex AB | Director/Board Member Director/Board Member | ||
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Biotechnology | Chairman Chief Executive Officer | |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Chairman Director/Board Member | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member | |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Chairman Director/Board Member | |
Maida Vale Capital AB
 Maida Vale Capital AB Investment Banks/BrokersFinance Maida Vale Capital AB is a private company based in Saltsjo-Boo, Sweden. The CEO of the Swedish company is Oliver Aleksov. | Investment Banks/Brokers | Director/Board Member Chairman | |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Founder General Counsel | |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
InDex Diagnostics AB
 InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The private company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
Astion Pharma A/S
 Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Astion Pharma A/S develops and manufactures pharmaceutical products. It focuses on developing anti-inflammatory drugs for dermatological and immunological diseases. The company was founded by Morten S. Weidner in 1992 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
MIVAC Development AB
 MIVAC Development AB BiotechnologyHealth Technology MIVAC Development AB develops treatment of autoimmune diseases and mucosal vaccine. The company was founded in 2008 and is headquartered in Goteborg, Sweden. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| ALLENEX AB | Biotechnology | Chairman Chief Operating Officer | |
TikoMed AB
 TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Founder | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| Stockholm School of Economics | College/University | Undergraduate Degree Masters Business Admin | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Adiposs SA
 Adiposs SA Medical SpecialtiesHealth Technology Adiposs SA is a Swiss medical imaging company that has developed imagebat-enhanced CT scan technology. The company is based in Plan-les-Ouates, Switzerland. The technology is fast, pain-free, and can be made available in every hospital and organization worldwide that provides CT scans. The company's co-inventor, Andrej Babic, has co-authored more than 30 scientific papers and holds several patents in the fields of medical imaging, photodynamic therapy, and nanotechnology. The company's team includes experts in preclinical development, clinical trials, and drug development across multiple therapeutic areas. Adiposs was founded by Nathalie Stransky-Heilkron, Andrej Babic, and Justyna Plewka Ma. Andrej Babic has been the CEO since incorporation. | Medical Specialties | Chairman | |
NM Pharma AS
 NM Pharma AS Pharmaceuticals: MajorHealth Technology NM Pharma AS manufactures and markets generic pharmaceuticals. It produces anti-inflammatory and cardiovascular agents and other prescription medicines and consumer health care products. The company is headquartered in Oslo, Norway | Pharmaceuticals: Major | Chief Executive Officer | |
| Farmos Group AB | Chief Executive Officer | ||
| MYCB1 Group BV | Chairman | ||
| Cilag AB | Chief Executive Officer | ||
Hansen Conference & Event AB
 Hansen Conference & Event AB Miscellaneous Commercial ServicesCommercial Services Hansen Conference & Event AB provides event planning services. The firm's services by type include conference trip, conference, congress, field trip and incentive travel. The company was founded in 1989 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BARINTHUS BIOTHERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Biomatcell AB
 Biomatcell AB BiotechnologyHealth Technology Biomatcell AB operates as a holding company that commercializes inventions in the fields of biomaterial science and cell therapy by licensing its inventions and creating spin-off companies. It develops three-dimensional biomaterial scaffold geometries in bioactive ceramics and metals. It markets products and services based on research in the field of biomaterials and stem cells and patenting new ideas in the same area. The company was founded on May 11, 2004 and is headquartered in Gothenburg, Sweden. | Biotechnology | Chairman | |
| LFF Service AB | Chief Executive Officer | ||
CUBE Labs Srl
 CUBE Labs Srl Investment ManagersFinance Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy. | Investment Managers | Consultant / Advisor | |
| MRGN Advisors SARL | Chief Executive Officer | ||
| MYCB1 BV | Chairman |
Statistiques
Internationale
| Suède | 34 |
| Danemark | 6 |
| Norvège | 3 |
| Royaume-Uni | 3 |
| Etats-Unis | 3 |
Sectorielle
| Health Technology | 31 |
| Consumer Services | 7 |
| Commercial Services | 4 |
| Finance | 4 |
| Distribution Services | 2 |
Opérationnelle
| Director/Board Member | 223 |
| Corporate Officer/Principal | 71 |
| Chairman | 67 |
| Chief Executive Officer | 44 |
| Independent Dir/Board Member | 34 |
Relations les plus connectées
| Insiders | |
|---|---|
| Eva Agneta Edberg | 45 |
| Viktor Drvota | 41 |
| Pierre Armand Morgon | 29 |
| Mattias Klintemar | 28 |
| Ted Ingemar Jakob Fjällman | 23 |
| Torsten Rüdiger Goesch | 23 |
| Karl Blom | 22 |
| Hugo Petit | 21 |
| Anders Waas | 21 |
| Jan Nils Sandström | 20 |
| Gunnar Mattsson | 16 |
| Henrik Kristian Moltke | 16 |
| Marianne Kock | 16 |
| Achim Kaufhold | 14 |
| Per-Göran Gillberg | 11 |
- Bourse
- Insiders
- Lena Birgitta Degling Wikingsson
- Connexions Sociétés
